Vaccination

(asked on 6th February 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to his policy paper Tackling antimicrobial resistance 2019 to 2024: the UK's 5-year national action plan, if he will amend the code of practice for the Joint Committee on Vaccination and Immunisation to require that Committee to assess the effect on the level of anti-microbial resistance of (a) a new, (b) major changes to and (c) the discontinuation of an immunisation programme.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 14th February 2019

The Joint Committee on Vaccination and Immunisation’s (JCVI’s) terms of reference is to advise the United Kingdom health departments on immunisations for the prevention of infections and/or disease following due consideration of the evidence on the burden of disease, on vaccine safety and efficacy and on the impact and cost effectiveness of immunisation strategies.

JCVI is aware that vaccination has an important role in controlling antimicrobial resistance. As most resistant infections are healthcare associated, the new JCVI Healthcare Associated Infections Working Group, set up to review and provide preliminary advice to JCVI on the potential use of appropriate vaccines in the UK, will help to address this issue.

Reticulating Splines